MDXG PB Ratio
3.00×TTM
Retrieved:
MDXG FY P/B Ratio
9160.43×-2048.91×
2006-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.
MDXG pb ratio history
Price-to-book ratio. The available annual fiscal periods series contains 20 observations from Dec 31, 2006 to Dec 31, 2025.
| Period ending | PB Ratio |
|---|---|
| 3.9001× | |
| 7.322× | |
| 7.1587× | |
| 4.2129× | |
| 7.1999× | |
| 10.7525× | |
| 23.5669× | |
| 3.8066× | |
| 18.6655× | |
| 7.0566× | |
| 9.1914× | |
| 13.6551× | |
| 11.4389× | |
| 15.6704× | |
| 6.8817× | |
| 13.0869× | |
| 4.5368× | |
| 1.7915× | |
| -964.1386× | |
| 8,075.6554× |
Compare pb ratio
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) pb ratio
- Bridgebio Pharma Inc (BBIO) pb ratio
- Brightspring Health Services Inc (BTSG) pb ratio
- Madrigal Pharmaceuticals Inc (MDGL) pb ratio
- Ensign Group Inc (ENSG) pb ratio
- Glaukos Corp (GKOS) pb ratio
- Vaxcyte Inc (PCVX) pb ratio
- Krystal Biotech Inc (KRYS) pb ratio
Compare all covered stocks by pb ratio →
All MDXG financial metrics · MDXG stock overview · How to interpret financial metrics